Trial intelligence / Profile preview

AdoMet and Betaine in HCV Non-Responders

NCT00310336Phase 3Completed

Sponsor
University Hospital Basel
Start
Aug 2006
Primary completion
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of S-adenosylmethionine and betaine in hepatitis C virus infection, sponsored by University Hospital Basel. Primary endpoint: Sustained Response Rate. Started Aug 2006; status: completed.

02

Drugs

S-adenosylmethioninebetaine
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on NCT00310336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00310336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call